Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Friedmann Paul, MD, head, Clinical Neuroimmunology Research Group, NeuroCure Clinical Research Center, and head, Clinical and Experimental Neuroimmunology, Experimental and Clinical Research Center, Charité–Universitätsmedizin Berlin. He shared his perspective on the state of care in neuromyelitis optica spectrum disorder (NMOSD), the need to raise awareness for symptomatic care and patient challenges, and the potential of novel therapeutic approaches to improve care.
Episode Breakdown:
- 2:00 – State of diagnosis and care for NMOSD and similar disorders
- 6:00 – Role of NMOSD Awareness Month and advocacy efforts
- 8:45 – Current challenges with symptomatic management
- 11:20 – Multidisciplinary communication, coordination, and collaboration
- 13:05 – Neurology News Minute
- 16:45 – The potential of self-tolerization and curing NMOSD
- 19:05 – Nonpharmacologic approaches to care
- 20:40 – The need to improve physician awareness and education
- 22:45 – Advice for communicating the diagnosis to patients
- 24:45 – The need for patient advocacy groups
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Thanks for listening to the
NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit
neurologylive.com.